Market Overview

Syntrix Biosystems Announces Court Upholds $115M Patent Infringement Judgement Against Illumina

Share:
Related ILMN
3 Niche ETFs Breaking Out
Wedbush Securities Raises Price Target On Illumina On Higher Quality 4Q14 Results
Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog (Zacks)

Syntrix Biosystems is pleased to announce that a federal court in
Tacoma, Washington, has upheld a judgment for $115 million and an
eight-percent running royalty in a patent…

Syntrix Biosystems is pleased to announce that a federal court in
Tacoma, Washington, has upheld a judgment for $115 million and an
eight-percent running royalty in a patent infringement case the company
filed against Illumina, Inc. (NASDAQ: ILMN), a San Diego-based biotechnology firm. This
decision affirms the largest patent verdict in Washington state history
and an award that will likely be one of the largest of its type in the
nation this year.

In an order
filed on November 4th of this year, the Court denied
Illumina's motions for judgment as a matter of law and a new trial,
ruling that the underlying jury verdict was “the result of seven
citizens' hard work” and that it

See full press release

Posted-In: News Guidance Legal Global

 

Related Articles (ILMN)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→